{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:16:38Z","timestamp":1794582998165,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08390-w","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T09:04:13Z","timestamp":1780736653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["NSUN2\/m5C\/TPI1 axis promotes glycolysis and immune evasion in breast cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Xinming","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziteng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"1130","key":"8390_CR1","doi-asserted-by":"publisher","first-page":"20211033","DOI":"10.1259\/bjr.20211033","volume":"95","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. The Br J Radiol. 2022;95(1130):20211033. https:\/\/doi.org\/10.1259\/bjr.20211033.","journal-title":"The Br J Radiol"},{"key":"8390_CR2","doi-asserted-by":"publisher","first-page":"102339","DOI":"10.1016\/j.ctrv.2022.102339","volume":"104","author":"D Trapani","year":"2022","unstructured":"Trapani D, Ginsburg O, Fadelu T, Lin NU, Hassett M, Ilbawi AM, et al. Global challenges and policy solutions in breast cancer control. Cancer Treat Rev. 2022;104:102339. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102339.","journal-title":"Cancer Treat Rev"},{"key":"8390_CR3","doi-asserted-by":"publisher","first-page":"117792","DOI":"10.1016\/j.cca.2024.117792","volume":"555","author":"MR Abdul","year":"2024","unstructured":"Abdul MR, Palaniyandi T, Viswanathan S, Baskar G, Surendran H, Gangadharan S, et al. Biomarker-specific biosensors revolutionise breast cancer diagnosis. Clinica (Rome) Acta. 2024;555:117792. https:\/\/doi.org\/10.1016\/j.cca.2024.117792.","journal-title":"Clinica (Rome) Acta"},{"issue":"2","key":"8390_CR4","first-page":"171","volume":"104","author":"KP Trayes","year":"2021","unstructured":"Trayes KP, Cokenakes SEH. Cokenakes S: breast cancer treatment. AM FAM Physician. 2021;104(2):171\u201378.","journal-title":"AM FAM Physician"},{"issue":"3","key":"8390_CR5","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3390\/ijms24032606","volume":"24","author":"C Chelakkot","year":"2023","unstructured":"Chelakkot C, Chelakkot VS, Shin Y, Song K. Modulating glycolysis to improve cancer therapy. IJMS. 2023;24(3):2606. https:\/\/doi.org\/10.3390\/ijms24032606.","journal-title":"IJMS"},{"issue":"5","key":"8390_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s12094-019-02187-8","volume":"22","author":"Z Wu","year":"2020","unstructured":"Wu Z, Wu J, Zhao Q, Fu S, Jin J. Emerging roles of aerobic glycolysis in breast cancer. Clin Transl Oncol. 2020;22(5):631\u201346. https:\/\/doi.org\/10.1007\/s12094-019-02187-8.","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"8390_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"S Jhunjhunwala","year":"2021","unstructured":"Jhunjhunwala S, Hammer C, Delamarre L. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer. 2021;21(5):298\u2013312. https:\/\/doi.org\/10.1038\/s41568-021-00339-z.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"8390_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41565-021-01000-4","volume":"17","author":"T Saha","year":"2022","unstructured":"Saha T, Dash C, Jayabalan R, Khiste S, Kulkarni A, Kurmi K, et al. Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat. Nanotechnol. 2022;17(1):98\u2013106. https:\/\/doi.org\/10.1038\/s41565-021-01000-4.","journal-title":"Nat. Nanotechnol"},{"issue":"1","key":"8390_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12885-018-4441-3","volume":"18","author":"JP Bates","year":"2018","unstructured":"Bates JP, Derakhshandeh R, Jones L, Webb TJ. Mechanisms of immune evasion in breast cancer. BMC Cancer. 2018;18(1):556. https:\/\/doi.org\/10.1186\/s12885-018-4441-3.","journal-title":"BMC Cancer"},{"issue":"6","key":"8390_CR10","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2741\/4847","volume":"25","author":"R Nirmaladevi","year":"2020","unstructured":"Nirmaladevi R. Epigenetic alterations in cancer. FRONT BIOSCI-LANDMRK. 2020;25(6):1058\u2013109. https:\/\/doi.org\/10.2741\/4847.","journal-title":"FRONT BIOSCI-LANDMRK"},{"issue":"2","key":"8390_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41416-023-02275-1","volume":"129","author":"Q Tang","year":"2023","unstructured":"Tang Q, Li L, Wang Y, Wu P, Hou X, Ouyang J, et al. RNA modifications in cancer. Br J Cancer. 2023;129(2):204\u201321. https:\/\/doi.org\/10.1038\/s41416-023-02275-1.","journal-title":"Br J Cancer"},{"issue":"2","key":"8390_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/genes10020102","volume":"10","author":"KE Bohnsack","year":"2019","unstructured":"Bohnsack KE, Hobartner C, Bohnsack MT. Eukaryotic 5-methylcytosine (m5C) RNA methyltransferases: mechanisms, cellular functions, and links to disease. GENES-BASEL. 2019;10(2):102. https:\/\/doi.org\/10.3390\/genes10020102.","journal-title":"GENES-BASEL"},{"issue":"8","key":"8390_CR13","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3390\/cells9081758","volume":"9","author":"A Chellamuthu","year":"2020","unstructured":"Chellamuthu A, Gray SG. The RNA methyltransferase NSUN2 and its potential roles in cancer. CELLS-BASEL. 2020;9(8):1758. https:\/\/doi.org\/10.3390\/cells9081758.","journal-title":"CELLS-BASEL"},{"issue":"1","key":"8390_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12967-022-03427-2","volume":"20","author":"M Li","year":"2022","unstructured":"Li M, Tao Z, Zhao Y, Li L, Zheng J, Li Z, et al. 5-methylcytosine RNA methyltransferases and their potential roles in cancer. J Transl Med. 2022;20(1):214. https:\/\/doi.org\/10.1186\/s12967-022-03427-2.","journal-title":"J Transl Med"},{"key":"8390_CR15","doi-asserted-by":"publisher","first-page":"105018","DOI":"10.1016\/j.tiv.2020.105018","volume":"70","author":"GM Vedoya","year":"2021","unstructured":"Vedoya GM, Lopez MM, Martin GA. The secretome of non-tumorigenic mammary cells MCF-10A elicits DNA damage in MCF-7 and MDA-MB-231 breast cancer cells. Toxicol Vitro. 2021;70:105018. https:\/\/doi.org\/10.1016\/j.tiv.2020.105018.","journal-title":"Toxicol Vitro"},{"issue":"1","key":"8390_CR16","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/s41467-021-22173-5","volume":"12","author":"M Shang","year":"2021","unstructured":"Shang M, Yang H, Yang R, Chen T, Fu Y, Li Y, et al. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nat Commun. 2021;12(1):1940. https:\/\/doi.org\/10.1038\/s41467-021-22173-5.","journal-title":"Nat Commun"},{"issue":"10","key":"8390_CR17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.cub.2006.04.027","volume":"16","author":"M Frye","year":"2006","unstructured":"Frye M, Watt FM. The RNA methyltransferase misu (NSun2) mediates myc-induced proliferation and is upregulated in tumors. Curr Biol. 2006;16(10):971\u201381. https:\/\/doi.org\/10.1016\/j.cub.2006.04.027.","journal-title":"Curr Biol"},{"key":"8390_CR18","doi-asserted-by":"publisher","unstructured":"Zou S, Huang Y, Yang Z, Zhang J, Meng M, Zhang Y, et al. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization. Clin Transl Med. 2024;14(3):e1621. https:\/\/doi.org\/10.1002\/ctm2.1621.","DOI":"10.1002\/ctm2.1621"},{"issue":"4","key":"8390_CR19","doi-asserted-by":"publisher","first-page":"106793","DOI":"10.1016\/j.jbc.2024.106793","volume":"300","author":"Y Chen","year":"2024","unstructured":"Chen Y, Jiang Z, Zhang C, Zhang L, Chen H, Xiao N, et al. 5-methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer. J Biol Chem. 2024;300(4):106793. https:\/\/doi.org\/10.1016\/j.jbc.2024.106793.","journal-title":"J Biol Chem"},{"key":"8390_CR20","doi-asserted-by":"publisher","unstructured":"Li P, Wang W, Zhou R, Ding Y, Li X. The m(5) C methyltransferase NSUN2 promotes codon-dependent oncogenic translation by stabilising tRNA in anaplastic thyroid cancer. Clin Transl Med. 2023;13(11):e1466. https:\/\/doi.org\/10.1002\/ctm2.1466.","DOI":"10.1002\/ctm2.1466"},{"issue":"9","key":"8390_CR21","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41419-021-04127-3","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu Y, Chen C, Tong X, Chen S, Hu X, Pan B, et al. NSUN2 modified by SUMO-2\/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death Dis. 2021;12(9):842. https:\/\/doi.org\/10.1038\/s41419-021-04127-3.","journal-title":"Cell Death Dis"},{"issue":"1","key":"8390_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13058-024-01847-0","volume":"26","author":"X Zhang","year":"2024","unstructured":"Zhang X, An K, Ge X, Sun Y, Wei J, Ren W, et al. NSUN2\/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m5C methylation. Breast Cancer Res. 2024;26(1):94. https:\/\/doi.org\/10.1186\/s13058-024-01847-0.","journal-title":"Breast Cancer Res"},{"key":"8390_CR23","doi-asserted-by":"publisher","first-page":"111112","DOI":"10.1016\/j.cellsig.2024.111112","volume":"117","author":"X Wang","year":"2024","unstructured":"Wang X, Liu D, Hua K, Fang L. LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1. Cellular Signalling. 2024;117:111112. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111112.","journal-title":"Cellular Signalling"},{"issue":"13","key":"8390_CR24","doi-asserted-by":"publisher","first-page":"20751","DOI":"10.18632\/oncotarget.10612","volume":"8","author":"J Yi","year":"2017","unstructured":"Yi J, Gao R, Chen Y, Yang Z, Han P, Zhang H, et al. Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer. Oncotarget. 2017;8(13):20751\u201365. https:\/\/doi.org\/10.18632\/oncotarget.10612.","journal-title":"Oncotarget"},{"key":"8390_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.biochi.2024.01.003","volume":"220","author":"AB Littleflower","year":"2024","unstructured":"Littleflower AB, Parambil ST, Antony GR, Subhadradevi L. The determinants of metabolic discrepancies in aerobic glycolysis: providing potential targets for breast cancer treatment. BIOCHIMIE. 2024;220:107\u201321. https:\/\/doi.org\/10.1016\/j.biochi.2024.01.003.","journal-title":"BIOCHIMIE"},{"issue":"1","key":"8390_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbcan.2017.04.002","volume":"1868","author":"S Ganapathy-Kanniappan","year":"2017","unstructured":"Ganapathy-Kanniappan S. Linking tumor glycolysis and immune evasion in cancer: emerging concepts and therapeutic opportunities. BBA-REV CANCER. Biochim et Biophys Acta (BBA) - Rev Cancer. 2017;1868(1):212\u201320. https:\/\/doi.org\/10.1016\/j.bbcan.2017.04.002.","journal-title":"Biochim et Biophys Acta (BBA) - Rev Cancer"},{"key":"8390_CR27","doi-asserted-by":"publisher","first-page":"1189953","DOI":"10.3389\/fimmu.2023.1189953","volume":"14","author":"J Lin","year":"2023","unstructured":"Lin J, Fang W, Xiang Z, Wang Q, Cheng H, Chen S, et al. Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion. Front Immunol. 2023;14:1189953. https:\/\/doi.org\/10.3389\/fimmu.2023.1189953.","journal-title":"Front Immunol"},{"issue":"4","key":"8390_CR28","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.bbrc.2016.11.156","volume":"482","author":"H Jiang","year":"2017","unstructured":"Jiang H, Ma N, Shang Y, Zhou W, Chen T, Guan D, et al. Triosephosphate isomerase 1 suppresses growth, migration and invasion of hepatocellular carcinoma cells. Biochem Bioph Res Co. 2017;482(4):1048\u201353. https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.156.","journal-title":"Biochem Bioph Res Co"},{"issue":"12","key":"8390_CR29","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.bbadis.2009.09.012","volume":"1792","author":"F Orosz","year":"2009","unstructured":"Orosz F, Olah J, Ovadi J. Triosephosphate isomerase deficiency: new insights into an enigmatic disease. Biochim Et Biophys Acta (BBA) - Mol Basis Disease. 2009;1792(12):1168\u201374. https:\/\/doi.org\/10.1016\/j.bbadis.2009.09.012.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"4","key":"8390_CR30","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1158\/2159-8290.CD-22-0805","volume":"13","author":"BD Stein","year":"2023","unstructured":"Stein BD, Ferrarone JR, Gardner EE, Chang JW, Wu D, Hollstein PE, et al. LKB1-dependent regulation of TPI1 creates a divergent metabolic liability between human and mouse lung adenocarcinoma. Cancer Discov. 2023;13(4):1002\u201325. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0805.","journal-title":"Cancer Discov"},{"issue":"8","key":"8390_CR31","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/j.cmet.2024.07.008","volume":"36","author":"C Mo","year":"2024","unstructured":"Mo C, Li H, Yan M, Xu S, Wu J, Li J, et al. Dopaminylation of endothelial TPI1 suppresses ferroptotic angiocrine signals to promote lung regeneration over fibrosis. Cell Metab. 2024;36(8):1839\u201357.e12. https:\/\/doi.org\/10.1016\/j.cmet.2024.07.008.","journal-title":"Cell Metab"},{"issue":"1","key":"8390_CR32","doi-asserted-by":"publisher","first-page":"2384889","DOI":"10.1080\/08916934.2024.2384889","volume":"57","author":"J Xia","year":"2024","unstructured":"Xia J, Qiao Z, Hao X, Zhang Y. LDHA-induced histone lactylation mediates the development of osteoarthritis through regulating the transcription activity of TPI1 gene. AUTOIMMUNITY. 2024;57(1):2384889. https:\/\/doi.org\/10.1080\/08916934.2024.2384889.","journal-title":"AUTOIMMUNITY"},{"issue":"1","key":"8390_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12967-022-03370-2","volume":"20","author":"X Jin","year":"2022","unstructured":"Jin X, Wang D, Lei M, Guo Y, Cui Y, Chen F, et al. TPI1 activates the PI3K\/AKT\/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5. J Transl Med. 2022;20(1):191. https:\/\/doi.org\/10.1186\/s12967-022-03370-2.","journal-title":"J Transl Med"},{"issue":"3","key":"8390_CR34","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/ptr.7661","volume":"37","author":"H Xu","year":"2023","unstructured":"Xu H, Li L, Qu L, Tu J, Sun X, Liu X, et al. Atractylenolide-1 affects glycolysis\/gluconeogenesis by downregulating the expression of TPI1 and GPI to inhibit the proliferation and invasion of human triple-negative breast cancer cells. Phytotherapy Res. 2023;37(3):820\u201333. https:\/\/doi.org\/10.1002\/ptr.7661.","journal-title":"Phytotherapy Res"},{"key":"8390_CR35","doi-asserted-by":"publisher","unstructured":"Chen YS, Yang WL, Zhao YL, Yang YG. Dynamic transcriptomic m(5)C and its regulatory role in RNA processing. WIREs RNA. 2021;12(4):e1639. https:\/\/doi.org\/10.1002\/wrna.1639.","DOI":"10.1002\/wrna.1639"},{"issue":"2","key":"8390_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41419-024-06527-7","volume":"15","author":"T Xu","year":"2024","unstructured":"Xu T, Xiong M, Hong Q, Pan B, Xu M, Wang Y, et al. Hsa_circ_0007990 promotes breast cancer growth via inhibiting YBX1 protein degradation to activate E2F1 transcription. Cell Death Dis. 2024;15(2):153. https:\/\/doi.org\/10.1038\/s41419-024-06527-7.","journal-title":"Cell Death Dis"},{"issue":"1","key":"8390_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12967-021-03206-5","volume":"20","author":"Y Lin","year":"2022","unstructured":"Lin Y, Zhang J, Li Y, Guo W, Chen L, Chen M, et al. CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1. J Transl Med. 2022;20(1):17. https:\/\/doi.org\/10.1186\/s12967-021-03206-5.","journal-title":"J Transl Med"},{"issue":"10","key":"8390_CR38","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.7150\/ijbs.115610","volume":"21","author":"J He","year":"2025","unstructured":"He J, Liu B, Zhao W, Shen H, Wang Y, Li W, et al. The glucose sensor NSUN2-m 5 C modification regulates tumor-immune glucose metabolism reprogramming to drive hepatocellular carcinoma evolution. Int. J. Biol. Sci. 2025;21(10):4529\u201348. https:\/\/doi.org\/10.7150\/ijbs.115610.","journal-title":"Int. J. Biol. Sci"},{"key":"8390_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.semcancer.2019.12.003","volume":"72","author":"S Vranic","year":"2021","unstructured":"Vranic S, Cyprian FS, Gatalica Z, Palazzo J. PD-L1 status in breast cancer: current view and perspectives. Semin Cancer Biol. 2021;72:146\u201354. https:\/\/doi.org\/10.1016\/j.semcancer.2019.12.003.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"8390_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1158\/1078-0432.CCR-16-3001","volume":"24","author":"LA Emens","year":"2018","unstructured":"Emens LA. Breast cancer immunotherapy: facts and hopes. Clin Cancer Res. 2018;24(3):511\u201320. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3001.","journal-title":"Clin Cancer Res"},{"issue":"14","key":"8390_CR41","doi-asserted-by":"publisher","first-page":"7517","DOI":"10.3390\/ijms25147517","volume":"25","author":"K Dvir","year":"2024","unstructured":"Dvir K, Giordano S, Leone JP. Immunotherapy in breast cancer. IJMS. 2024;25(14):7517. https:\/\/doi.org\/10.3390\/ijms25147517.","journal-title":"IJMS"},{"issue":"3","key":"8390_CR42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10549-019-05130-1","volume":"174","author":"ES Stovgaard","year":"2019","unstructured":"Stovgaard ES, Dyhl-Polk A, Roslind A, Balslev E, Nielsen D. PD-L1 expression in breast cancer: expression in subtypes and prognostic significance: a systematic review. Breast Cancer Res Treat. 2019;174(3):571\u201384. https:\/\/doi.org\/10.1007\/s10549-019-05130-1.","journal-title":"Breast Cancer Res Treat"},{"key":"8390_CR43","doi-asserted-by":"crossref","unstructured":"Fan R, Baysoy A, Tian X, Zhang F, Renauer P, Bai Z, et al. Spatially resolved panoramic in vivo CRISPR screen via Perturb-DBiT. Res Square. 2025;3\u20136481967.","DOI":"10.21203\/rs.3.rs-6481967\/v1"},{"issue":"10","key":"8390_CR44","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41587-023-01676-0","volume":"41","author":"Y Liu","year":"2023","unstructured":"Liu Y, DiStasio M, Su G, Asashima H, Enninful A, Qin X, et al. High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq. NAT Biotechnol. 2023;41(10):1405\u201309. https:\/\/doi.org\/10.1038\/s41587-023-01676-0.","journal-title":"NAT Biotechnol"},{"key":"8390_CR45","doi-asserted-by":"crossref","unstructured":"Fan R, Zhang D, Rodr\u00edguez-Kirby L, Lin Y, Song M, Wang L, et al. Spatial dynamics of mammalian brain development and neuroinflammation by multimodal tri-omics mapping. Res Square. 2024;3\u20134814866.","DOI":"10.1101\/2024.07.28.605493"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08390-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08390-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08390-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:41:58Z","timestamp":1786578118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08390-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8390"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08390-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Affiliated Hospital of Guangdong Medical University (YJYS2025272).This study was performed in line with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Affiliated Hospital of Guangdong Medical University (GDMU2024-187).All animal experiments should comply with the ARRIVE guidelines.All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Animal study","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1039"}}